2004
DOI: 10.1016/j.imlet.2004.03.014
|View full text |Cite
|
Sign up to set email alerts
|

Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
34
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(35 citation statements)
references
References 55 publications
1
34
0
Order By: Relevance
“…44 Moreover, it has been recently suggested than ECs themselves play a far more direct role in immunity. 45 Our results indicate that CD40 signaling in ECs leads to transcriptional induction of several immunityrelated molecules and actively contributes to the transformation of ECs to antigen-presenting cells (Document S1, "Immunity"). Thus, CD40-mediated leukocyte-endothelial cell interactions appear to influence immune cell function through antigen presentation and directly affect adaptive immunity, inducing transendothelial migration and/or polarization of different T-cell subsets.…”
Section: Discussionmentioning
confidence: 75%
“…44 Moreover, it has been recently suggested than ECs themselves play a far more direct role in immunity. 45 Our results indicate that CD40 signaling in ECs leads to transcriptional induction of several immunityrelated molecules and actively contributes to the transformation of ECs to antigen-presenting cells (Document S1, "Immunity"). Thus, CD40-mediated leukocyte-endothelial cell interactions appear to influence immune cell function through antigen presentation and directly affect adaptive immunity, inducing transendothelial migration and/or polarization of different T-cell subsets.…”
Section: Discussionmentioning
confidence: 75%
“…This action has been documented in vitro, but whether it occurs in vivo is still debatable, although ECs from different species express various accessory molecules, including CD80, CD86, ICOS-L, programmed death ligand 1, programmed death ligand 2, LFA-3, CD40, and CD134L (40). Therefore, the impact of ECs on adaptive immunity may be exerted through their interaction with leukocytes and platelets.…”
Section: Adaptive Immunitymentioning
confidence: 99%
“…With respect to the former, it has become increasingly appreciated that non-hematopoietic peripheral (or 'stromal') APCs play critical, non-redundant roles (i.e., compared to hematopoietic APCs) in shaping adaptive immune responses [16][17][18] . Among such 'semiprofessional' APCs, vascular and lymphatic endothelial cells (which vastly outnumber professional APCs) are among the best appreciated [16][17][18] . However, the details of signaling events and their coupled immunological synapses remain largely uninvestigated.…”
Section: Discussionmentioning
confidence: 99%
“…Though still understudied, vascular and lymphatic endothelial cells are emerging as a large (i.e., greater in numbers than all professional APCs, by ~1,000-fold) peripheral compartment of 'semi-professional' APCs [16][17][18] . These cells express MHC-I-, MHC-II-and a multitude of co-stimulator molecules (e.g., CD40, LFA3, ICOSL, 4-1BB, OX40L, TL1A, PD-L1; but not CD80 and CD86) and are strategically positioned at the blood-tissue interface where they serve specialized sentinel functions [16][17][18] .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation